On Wednesday 26 June, the European Commission announced that it had approved, subject to certain conditions, the proposed acquisition of the European OTC business of Viatris Inc., which includes personal care pharmaceutical products, by CVC’s Cooper Consumer Health S.A.S..
Following its preliminary investigation, the European Commission concluded that the acquisition, as initially notified, would have reduced competition in the market for certain pharmaceutical products.
In order to...